Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)

UENO, Asami

doi:10.1136/bmjdrc-2024-004237

ID	68773
Title Alternative	血漿アンギオテンシン変換酵素2（ACE2）は糖尿病関連腎臓病（DKD）の腎予後予測因子となり得る（U-CARE study 3）
FullText URL	K0007213_abstract_review.pdf 349 KB K0007213_fulltext.pdf 1010 KB K0007213_summary.pdf 205 KB
Author	UENO, Asami Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Note	岡山大学審査学位論文 Ueno A, Onishi Y, Mise K, et al. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3). BMJ Open Diabetes Res Care. 2024;12(3):e004237. Published 2024 May 30. doi:10.1136/bmjdrc-2024-004237
Published Date	2025-03-25
Content Type	Thesis or Dissertation
Grant Number	甲第7213号
Granted Date	2025-03-25
Thesis Type	Doctor of Philosophy in Medical Science
Grantor	岡山大学
Thesis FullText	Thesis or Dissertation (See FullText URL)
Related Url	isVersionOf https://doi.org/10.1136/bmjdrc-2024-004237
language	English
File Version	ETD
Grant ID	15301甲第7213号
PubMed ID	38816205
Copyright Holders	© Author(s) (or their employer(s)) 2024.
DOI	10.1136/bmjdrc-2024-004237
License	http://creativecommons.org/licenses/by-nc/4.0/